Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
China Life Insurance A | Shanghai | Financial | Insurance | CN¥1.27T | 14.6x | 0.11 | CN¥44.68 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -15.8% Downside | Upgrade to Pro+ | |
Ping An Insurance | Shanghai | Financial | Insurance | CN¥1.02T | 8.6x | 0.84 | CN¥55.80 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.3% Upside | Upgrade to Pro+ | |
People's Insurance | Shanghai | Financial | Insurance | CN¥294.07B | 4.6x | 0.1 | CN¥7.22 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.6% Downside | Upgrade to Pro+ | |
China Pacific Insurance | Shanghai | Financial | Insurance | CN¥224.33B | 5.3x | 0.19 | CN¥35.06 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7% Upside | Upgrade to Pro+ | |
New China Life Insurance | Shanghai | Financial | Insurance | CN¥69.99B | 3.5x | -0.19 | CN¥50.37 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -28.9% Downside | Upgrade to Pro+ | |
COFCO Capital Holdings | Shenzhen | Financial | Insurance | CN¥37.10B | 27.4x | 2.83 | CN¥16.10 | -4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hubei Biocause Pharmaceutical | Shenzhen | Financial | Insurance | CN¥19.42B | -25.5x | 0.1 | CN¥3.93 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiangxi Tianli Technology INC | Shenzhen | Financial | Insurance | CN¥4.91B | 136.4x | 0.34 | CN¥24.83 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |